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The study aims to describe the distribution of patients with type 2 diabetes (T2D) by care
plan and to highlight determinants of underuse and overuse of integrated care (IC). This
cross-sectional study included all T2D patients resident in Reggio Emilia on 31/12/2015
based on the population-based diabetes registry. Eligibility for IC requires good glycaemic
control, no rapid insulin, no kidney failure and no diabetes complications. We calculated the
proportion of IC underuse and overuse and adjusted prevalence estimate using multivariate
logistic regression. Determinants were age, sex, citizenship, district of residence and time
since diagnosis. Of 29,776 patients, 15,364 (51.6%) were in diabetes clinic plan, 9851
(33.1%) in IC plan and 4561 (15.3%) not in any care plan (i.e., in Other group). There were
10,906 (36.6%) patients eligible for IC, of whom 1000 in Other group. When we adjusted for
all covariates and restricted the analysis to patients included in care plans, the proportion of
those eligible for IC plan but cared for in diabetes clinic plan (i.e. underuse of IC) was 28%
(n = 3028/9906; 95%CI 27–29). Similarly, the proportion of those not eligible for IC but cared
for in IC plan (i.e. overuse of IC) was 11% (n = 1720/11,896; 95%CI 10–11).The main deter-
minant of both IC underuse and overuse was the district of residence. Foreign status was
associated with underuse (37%; 95%CI 33–43), while old age (�80 years) with both under-
use (36%; 95%CI 0.33–0.38) and overuse (23%; 95%CI 22–25). The criterion for suspen-
sion of IC plan most frequently found was renal failure, followed by hospitalization for
diabetes-related complications. Patients are more often allocated to more specialized set-
tings than not. Healthcare provider-related factors are the main determinants of inappropri-
ate setting allocation.
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Introduction
Diabetes has reached pandemic proportions, affecting almost 415 million people globally in
2015, with an increasing prevalence trend [1,2]. Type 2 diabetes (T2D) is a multifactorial
chronic disease and represents one of the main risk factors for cardiovascular diseases, the
leading cause of death and disability in developed countries [3,4]. Moreover, diabetes impairs
quality of life and psychological well-being, including in terms of disability-adjusted life years
(DALY) [4–6]. Indeed, the burden of diabetes is significant in terms of morbidity and mortal-
ity, but also has a relevant impact on socioeconomic and healthcare-related costs, especially
due to diabetes-related long-term complications [7].
In the last decades, diabetic outpatient clinics (DC) have been set up in many countries,
including in Italy [8–11], where usual care of T2D requires a referral by a general practitioner
(GP) to a DC for diagnostic confirmation, treatment, prevention and early diagnosis of com-
plications through close patient follow up by a team of diabetologists, nurses and dieticians,
and for scheduling of regular follow up visits. This model of care is quite intensive and
resource-consuming, and diabetic clinics have limited capabilities. Moreover, not all the
phases of care require the same level of expertise or have the same level of complexity [12].
Recently, many healthcare systems have adopted a model of integrated care involving special-
ists in the most critical phases and for more complicated patients, while GPs take care of the
routine management of the disease in less complex cases [9,13,14]. In this context, evidence on
the effectiveness of shared care is growing [15,16].
In Italy, the 2010 Italian Standards for the Treatment of Diabetes Mellitus recommended
the adoption of an integrated care model for patients with uncomplicated diabetes [17].
The Local Health Authority (LHA) in the Reggio Emilia province gradually introduced the
integrated care (IC) plan starting in 2004 as a pilot project involving both diabetes clinics and
GPs and targeting the T2D patients at low risk of complications [18]. Implementation took
place over time and across GPs due to organizational and logistical factors and to GPs’ and
patients’ attitudes (participation in IC is voluntary for both patients and GPs). This pilot proj-
ect was consistent with the national project IGEA, a comprehensive strategy for implementing
a chronic disease management intervention for people with diabetes, integrating GPs and spe-
cialized clinics in the management of diabetes [19]. The Emilia-Romagna health authority
scaled up the IC project region-wide, issuing guidelines in 2009 that defined patients eligible
for integrated management of care [18], subsequently updated [20,21].
Although the eligibility criteria for IC have been defined, the accuracy in allocating T2D
patients to the correct care plan can be difficult. Indeed, inaccurate evaluation of eligibility cri-
teria or professionals’ or patients’ unwillingness to engage with IC may cause inappropriate
management: complicated patients may be allocated to a care plan that does not satisfy the
clinical complexities of their needs, while patients without complications may be allocated to a
care plan they do not really need. Finally, there are those patients who are not cared for in any
care plan.
The present study aims to describe the current distribution of T2D patients by care plan
and to highlight the main predictors of under- and overuse of integrated care plan.
Materials and methods
Study population and study design
Reggio Emilia province is situated in northern Italy and has approximatively 530,000 inhabi-
tants, 300 general practitioners, six outpatient diabetes clinics and one diabetes unit in the
main hospital.
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In this cross-sectional study we analyzed the allocation by care plan of T2D patients preva-
lent on 31/12/2015, then we classified them based on eligibility to IC to measure the propor-
tion of T2D patients not appropriately allocated. Finally, we described the determinants of
inappropriate allocation: overuse of integrated care plan, (i.e., ineligible patients allocated to
integrated care plan); underuse of integrated care plan, (i.e., eligible patients allocated to diabe-
tes clinic plan).
Description of the care model
Three groups of T2D patients were created: 1) exclusively cared for by DC from initial diag-
nostic assessment to periodic examinations and follow-up visits; 2) cared for both by GP and
diabetes clinic through an IC plan envisaging an initial assessment by DC and a quarterly fol-
low-up visit, one every two years at the DC, the others performed by GP; 3) Other-group (nei-
ther DC nor IC), perhaps only cared for by own GP but also voluntary opt-outs who turn to
private care and neglected patients.
Eligibility to IC criteria
Fig 1 shows the structure of the integrated care model and the eligibility criteria to IC plan,
defined according to regional guidelines criteria [18] (Fig 1). The algorithms used to assess eli-
gibility criteria to the IC plan from routinely-collected data are detailed in S1 and S2 Tables. In
brief, the required criteria are good glycaemic control, no rapid insulin, no kidney failure, and
no diabetes complications. Eligibility is assessed at the first visit at the diabetes clinic and re-
assessed during the follow-up visits. In the first visit, the unmet criteria induce the application
of the DC plan until the next scheduled visit; in the follow-up visit, if at least one criterion is
unmet, a suspension of the IC plan should be generated.
Outcomes, covariates and data sources
Outcomes were “care plan in use” and “eligibility to IC” (yes or no) for all T2D patients alive
and resident in Reggio Emilia province on December 31, 2015. Covariates were sex, age, citi-
zenship, district of residence and time since diabetes diagnosis. Demographic variables were
retrieved from civil registry while diabetes information was retrieved from the Reggio Emilia
Diabetes Registry (REDR), a validated registry created by the deterministic linkage of six rou-
tinely collected data sources through a definite algorithm able to ascertain cases and to distin-
guish the type of diabetes and model of care [22]. Data have been included since 2009, and the
REDR is updated annually. The date of inclusion in the registry is the date when a person first
meets one of the following inclusion criteria: (1) Disease-specific exemption database: exemp-
tion from co-payment due to diabetes; (2) Hospital discharge database: hospitalisation with
diabetes diagnosis in whichever position by ICD-9 (International Classification of Diseases
Clinical Modification, 9th Edition) codes 250.xx; 357.2x; 362.0x; 366.41; 648.0x, excluding
MDC14; (3) Biochemistry laboratory database: two glycated haemoglobin (HbA1c) test> =
6.5% (48 mmol/mol) or one HbA1c> = 6.5% and (48 mmol/mol) followed by one fasting
blood sugar test> = 126 mg/dl; (4) Drug prescription databases: at least two prescriptions of
antidiabetic drugs in pharmacy distribution database or only one included in direct-distribu-
tion database; (5) Diabetes outpatient clinic database: diagnosis by a diabetologist; (6) Mortal-
ity registry: cause of death by ICD-10 (International Classification of Diseases, 10th Edition)
codes E10 –E14. Women with gestational diabetes or women receiving treatment for a poly-
cystic ovarian syndrome or obesity were excluded. Cases initially notified to the registry
through record linkage were retained in case they were clinically confirmed by a diabetologist
or another physician.
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Statistical methods
We compared patients’ baseline characteristics stratified by current care plan (i.e. DC, IC and
other-group) and then we classified patients accordingly to appropriate allocation. We calcu-
lated the average predicted probabilities only for patients cared for by a care plan (i.e. IC or
DC), applying a multivariate logistic model and using remaining covariates at their mean val-
ues. The covariates were sex, age, district, time since diagnosis and citizenship. Allocation to
the correct care plan was used as a reference. Moreover, we calculated the intraclass correlation
(ICC) by using a three-level logistic model with random effects at the district and GP levels.
Finally, we described the distribution of ineligible patients by a number of met suspension cri-
teria, and we computed the probability of each suspension criterion. The analyses were per-
formed using the STATA statistical package Version 13.0.
Ethical approval
This is an observational study, and the data were collected retrospectively. The Local Health
Authority of Reggio Emilia was responsible for collecting and processing the data. The analyses
Fig 1. Integrated care model. Structure of the integrated care model and eligibility criteria to integrated care (IC) plan, defined according to regional guidelines criteria
[18]. �Or with different time interval according to clinical conditions; #Glomerular Filtration Rate level�60ml/min/1.73m2.
https://doi.org/10.1371/journal.pone.0219965.g001
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here presented are part of a larger study named "Reggio Emilia Diabetes Registry" and has
been approved by the provincial Ethics Committee on July 23, 2014 (Comitato Etico Provin-
ciale of Reggio Emilia, now Comitato Etico AVEN, after merging with the other Ethics Com-
mittees of the Modena, Piacenza and Parma provinces http://www.aou.mo.it/
ComitatoEticoAVEN). In accordance with the Italian privacy law, no patient or parental con-
sent is required for large retrospective population-based studies approved by the competent
Ethics Committee if data are published only in aggregated form.
Results
Based on REDR, as of December 31, 2015 the resident population with DM2 was 29,776 (5.5%
crude prevalence), of whom 9851 (33.1%) in IC plan, 15,364 (51.6%) cared for exclusively in
DC and 4561(15.3%) not included in any defined care plan. Those in the IC plan were more
likely to be aged 60–80 and with a more recent diagnosis than those cared for in DC. Relevant
differences in the proportions of patients in the IC plan were appreciable between districts,
and foreigners were more often cared for in DC. There were slightly more females among
those without any defined care plan, as there were patients over age 80 and foreigners, while
the newly diagnosed were appreciably more represented (Table 1).
Table 1. Characteristics of the study sample.
Distribution by care plan
Total IC DC Other
Subgroup N % N % N % N % P^
N 29776 9851 15364 4561
Sex (N;%) <0.0001
Females 13400 45.0 4434 45.0 6679 43.5 2287 50.1
Males 16376 55.0 5417 55.0 8685 56.5 2274 49.9
Age (N;%) <0.0001
<60 yr 6781 22.8 1847 18.7 3961 25.8 973 21.3
60–69 yr 7627 25.6 2736 27.8 3913 25.5 978 21.4
70–79 yr 8623 29.0 3166 32.1 4190 27.3 1267 27.8
80+ yr 6745 22.7 2102 21.3 3300 21.5 1343 29.4
District of residence (N;%) <0.0001
Mountain 2197 7.4 705 7.2 1166 7.6 326 7.1
Eastern plain 3250 10.9 1737 17.6 1262 8.2 251 5.5
Northern plain 4530 15.2 1794 18.2 2237 14.6 499 10.9
Western hills 3770 12.7 1125 11.4 2003 13.0 642 14.1
Capital 11773 39.5 2918 29.6 6868 44.7 1987 43.6
Eastern hills 4286 14.4 1572 16.0 1858 12.1 856 18.8
Time since diagnosis (N;%) <0.0001
<5 yr 8986 30.2 2993 30.4 3517 22.9 2476 54.3
5–9 yr 10594 35.6 4239 43.0 4624 30.1 1731 38.0
10+ 10196 34.2 2619 26.6 7223 47.0 354 7.8
Citizenship (N;%)
Italians 27561 92.6 9406 95.5 13968 90.9 4187 91.8 <0.0001
Foreigners 2215 7.4 445 4.5 1396 9.1 374 8.2
Current distribution of type 2 diabetes status by care plan (2015).
IC = integrated care plan; DC = diabetes clinic care plan; other = neither IC nor DC
^ p-value of the difference among care plans
https://doi.org/10.1371/journal.pone.0219965.t001
Determinants of inappropriate care setting allocation for type 2 diabetes patients in Reggio Emilia
PLOS ONE | https://doi.org/10.1371/journal.pone.0219965 July 22, 2019 5 / 12
Based on eligibility criteria, 10,906 (36.6%) T2D patients were eligible for IC plan and 6041
(20.3%) were not classifiable because the information was missing on some eligibility criteria.
Among the eligible patients, 6878 (63.1%) were correctly allocated to the IC plan. On the other
hand, 1720 patients in the IC plan should have been in the DC plan because at least one of the
suspension criteria was met, and 1253 was not classifiable. Among those in the DC plan, 3028
(20%) were eligible for IC plan, and 2160 were not classifiable. Finally, among those without
any defined care pathway, 2628 (58%) were not classifiable and the rest were almost equally eli-
gible and ineligible for IC plan (Fig 2).
When adjusting for all covariates, 28% of T2D patients eligible for IC plan were followed in
the DC plan (IC underuse), while 11% of ineligible T2D patients were cared for in the IC plan
(IC overuse) (Table 2).
The strongest predictor of IC underuse was the district of residence; the same was true for
IC overuse. In most cases, in districts where the proportion of underuse was lower than the
Fig 2. Distribution by care plan. Distribution of patients by eligibility criteria in different care plans. Unclassifiable = patients without the required laboratory
assessment (i.e., without a measure of HbA1c in 2015 and/or without a measure of glomerular filtration rate in 2014–2015); Should be in IC plan = patients satisfying
eligibility criteria; Should be in DC plan = patients with last 2015 HbA1c level> = 9% (75 mmol/mol) and/or at least one hospitalisation in 2012–2014 for diabetes-
related causes and/or rapid-acting insulin user in 2015 and/or with last 2014–2015 GFR level<60 ml/min/1.73m2). IC = integrated care plan, DC = diabetes clinic plan.
https://doi.org/10.1371/journal.pone.0219965.g002
Determinants of inappropriate care setting allocation for type 2 diabetes patients in Reggio Emilia
PLOS ONE | https://doi.org/10.1371/journal.pone.0219965 July 22, 2019 6 / 12
provincial average, the proportion of overuse was also higher than average, the only exception
being the mountain district, where both were above the average. No difference between males
and females was present, while older age was a determinant of both over- and underuse, and
people below age 60 had higher underuse and lower overuse. Small differences were also
observed in terms of the duration of disease: recently diagnosed patients had slightly higher
over- and underuse, while patients who had been diagnosed more than 10 years earlier had
higher underuse and lower overuse than average. Finally, foreigners had higher underuse and
higher overuse than did Italians.
The intraclass correlation for the three-level nested model for IC underuse was 0.10 at the
district level and 0.25 at the GP within-district level. For IC overuse model, the ICC was 0.05
and 0.12, respectively.
Most of the ineligible patients placed in the IC plan had only one criterion for suspension,
and only one patient met all criteria (Table 3A). The criterion for suspension most frequently
found in patients overusing the IC plan was renal damage, followed by hospitalization for dia-
betes-related complications in the previous three years and by high HbA1c (Table 3B).
Table 2. Probability of inappropriate care plan assignment.
Eligible to IC plan Ineligible to IC plan
Subgroup Total in IC In DC adjusted� Total in DC in IC adjusted�
P (unfit) 95%CI P(unfit) 95%CI
N 9906 6878 3028 0.28 0.27–0.29 11896 10176 1720 0.11 0.10–0.11
Sex
Females 4371 3086 1285 0.27 0.26–0.28 5304 4462 842 0.11 0.10–0.12
Males 5535 3792 1743 0.29 0.28–0.30 6592 5714 878 0.11 0.10–0.12
Age
<60 yr 2090 1361 729 0.33 0.30–0.35 2558 2416 142 0.04 0.03–0.05
60–69 yr 2779 2117 662 0.22 0.21–0.24 3027 2762 265 0.07 0.06–0.08
70–79 yr 3200 2253 947 0.27 0.26–0.29 3399 2820 579 0.15 0.14–0.17
80+ yr 1837 1147 690 0.35 0.33–0.38 2912 2178 734 0.23 0.22–0.25
District
Mountain 805 500 305 0.37 0.34–0.41 897 726 171 0.14 0.12–0.17
Eastern plain 1508 1351 157 0.10 0.08–0.11 1232 937 295 0.20 0.18–0.22
Northern plain 1535 1196 339 0.21 0.19–0.23 1862 1532 330 0.15 0.13–0.16
Western hills 1197 807 390 0.32 0.30–0.35 1554 1376 178 0.09 0.08–0.10
Capital 3425 1930 1495 0.44 0.42–0.45 4815 4381 434 0.07 0.06–0.08
Eastern hills 1436 1094 342 0.24 0.22–0.27 1536 1224 312 0.17 0.15–0.19
Time since diagnosis
<5 yr 3268 2192 1076 0.31 0.29–0.33 2175 1817 358 0.17 0.15–0.19
5–9 yr 3958 2961 997 0.23 0.21–0.24 3549 2808 741 0.18 0.17–0.20
10+ 2680 1725 955 0.34 0.32–0.36 6172 5551 621 0.07 0.06–0.07
Citizenship
Italians 9419 6579 2840 0.28 0.27–0.29 11023 9341 1682 0.11 0.11–0.12
Foreigners 487 299 188 0.38 0.33–0.43 873 835 38 0.05 0.04–0.07
Probability of inappropriate care plan assignment for patients with type 2 diabetes by patient characteristics. Eligible to IC = includes patients eligible to IC cared in DC
plan and patients in IC plan without suspension criteria. Ineligible to IC = includes patients not eligible to IC cared in DC plan and patients in IC plan with at least one
suspension criteria �Adjusted P (unfit): average predicted probabilities of inappropriate care plan assignment, obtained using a logistic multivariate model and using
remaining covariates at their mean values. The covariates were sex, age, district, time since diagnosis and citizenship. Placement in the correct care setting was used as a
reference.
https://doi.org/10.1371/journal.pone.0219965.t002
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Discussion
After several years since the introduction of the integrated care model, we found that only
one-third of patients are managed in the integrated care plan. Three figures contribute to the
proportion of integrated care plan use: only 37% of T2D patients fulfil the eligibility criteria,
37% of the eligible patients are not yet included, 15% of T2D patients are not included in any
care plan. The strongest predictor of IC plan underuse is the district of residence and thus pre-
sumably due to healthcare provider factors: GPs’ and diabetes clinics’ attitude and organiza-
tional factors of the facilities, such as the time of implementation of the IC plan. The districts
where underuse is lowest (i.e., the country districts of plain) are those with earliest IC care
model introduction, while in the urban district (capital including the city of Reggio Emilia),
where underuse is highest, there are still non-participating GPs. In districts with early IC care
model introduction, the number of patients initially eligible to IC plan that lost eligibility crite-
ria for aging or worsening of the disease could be higher than in the other districts. Moreover,
the GP-patient relationship may differ based on the context (rural vs urban); a rural setting
may facilitate the trust a patient has in disease management in primary care. Other factors
have a small impact on underuse. Also, overuse is mostly linked to the district of residence.
Nevertheless, the intraclass correlation measurements showed a weak clustering among dis-
tricts and GPs, although the latter was slightly higher than the former in the two models.
Finally, the T2D patients neither in IC nor in DC plan were more likely to be residents in
the urban district, to be older and to be recently diagnosed.
In a previous study, where the T2D patients were grouped in the same way, a higher per-
centage of patients neither in IC nor in DC plan (i.e., other-group) was found (36% vs. 15%),
and consequently the other two were lower (IC: 27% vs. 33%; DC: 37% vs. 52%)[23]. Likewise,
older patients were more likely to be part of other-group. In another study conducted in Turin
[24], the percentage of patients seen by diabetes clinic (equivalent to our DC + IC) was lower
(54% vs. our DC+IC = 85%). Once again, older patients were more likely to be part of other-
group (called GP in the Turin study). Neither of these studies analyzed the appropriateness of
adopted care plan based on eligibility criteria, focussing instead on adherence to recom-
mended guidelines for monitoring diabetes.
Table 3. Suspension criteria.
a.
N˚ of suspension criteria N˚ of patients %
Only 1 criterion 1,563 90.9
2 criteria 149 8.7
3 criteria 7 0.4
4 criteria 1 0.1
Total: 1720 100.0
b.
Criteria N˚ of patients P
eFGR 1123 0.65
At least 1 hosp. 409 0.24
HbA1c> = 9 241 0.14
Rapid insulin 113 0.07
Distribution by number (a.) and probability (P) (b.) of each met suspension criterion from the IC plan. Notes: the
sum of probabilities (P) calculated as n˚ of patients with a specific suspension criterion/total number of patients with
suspension criteria, exceeds 100% because many patients had more than one suspension criterion.
https://doi.org/10.1371/journal.pone.0219965.t003
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Overall, the proportion of IC plan underuse is relatively high, but cannot be considered as
inappropriate allocation per se. In fact, the inclusion in the integrated care plan is voluntary for
both patients and GPs. Furthermore, as our ability to assess complications other than renal failure
is limited by the available data sources, we probably overestimated the eligible population. This
point is critical because, according to our findings, the inclusion criteria proposed by the Italian
guidelines would limit the impact of the integrated model; even in the hypothesis of 100% appro-
priateness, only about one-third of patients could be allocated to the IC plan. Considering that,
according to the management protocol, these patients need a follow-up visit at the diabetes clinic
every two years, the IC plan does not dramatically decrease the diabetes clinic workload. Only less
stringent eligibility criteria for IC plan could increase the impact of this care model.
On the other hand, a proportion of T2D patients are allocated to the IC plan even though they
meet suspension criteria. By far the most disregarded criterion is the presence of renal failure. From
a clinical point of view, this criterion is particularly important because it requires immediate re-eval-
uation of oral hypoglycaemic drug therapy [12]. Indeed, in some cases, these signs can be related to
acute kidney injury rather than to chronic renal disease and the GP may have managed and resolved
the acute episode, not considering this a sufficient criterion to move the patient definitively to diabe-
tes clinic plan [25]. Despite this, it is now well recognized that while the glomerular filtration rate
generally improves after acute kidney injury, the renal recovery process is often incomplete and can
result in a chronic decrease in kidney function [26]. In this way, acute kidney injury increases the
risk of advanced chronic kidney disease by more than threefold, independently of other risk factors
of progression. Thus, even mild acute kidney injury in diabetic patients with relatively preserved
renal function should be viewed as a serious event deserving a specialized evaluation [25].
Moreover, only specialized physicians can prescribe oral hypoglycaemic drug-classes useful
for diabetic patients with chronic renal failure, such as iDPP4 or GLp1-analogs or Gliflozine.
Despite this, the characteristics of these drugs may make GPs more comfortable not to for-
mally change the care plan for these patients, who only need an annual therapeutic plan by dia-
betologists more than patients using metformin.
The most concerning finding in our study is the very high proportion of T2D patients with-
out HbA1c and renal function test results among those patients who are not included in any
formal care plan, compared to a previous study [24]. As for glycaemic control, the assessment
of renal function in individuals with T2D is also extremely important since diabetic nephropa-
thy constitutes a major cause of chronic kidney disease in the world, which makes diabetes the
most frequent cause of end-stage renal disease [27,28].
Approximately 40% of all diabetic patients develop diabetic nephropathy [29], which is the
most common diagnosis among individuals in renal replacement programmes, accounting for
up to 44% of cases [30].The patients not included in any formal care plan represent a very het-
erogeneous group, which includes recently diagnosed, not yet evaluated people who explicitly
do not want to be cared for by the public service, people who completely rely on their GP’s
care and difficult-to-reach subgroups. It is possible that some of these patients undergo labora-
tory tests in completely private settings that do not report data to the registry, but it is also
likely that some of these patients are actually underserved and not cared for. This hypothesis is
consistent with the worse prognosis observed in this group in a previous study on the same
population compared to patients in the IC or DC plan [16]. Therefore, the effort to reduce the
number of patients not included in any formal care plan should be a priority.
Strengths and limitations
This study assessed the adherence to the integrated care model, a chronic care approach for
diabetes that attempts to allocate patients to the appropriate setting and to reduce the workload
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for the more specialized clinics. As this aim is common to many other chronic care models,
our methodology and results could be useful in similar contexts to evaluate their performance
or to plan monitoring indicators. Our study identifies patients with diabetes through a popula-
tion-based registry that has a validated algorithm of case detection and is manually checked
for the accuracy of information. The nature of this data source allowed us to classify patients
into three groups, including those patients not in any defined care plan (i.e., in Other group).
Our data source does not capture the test results from private laboratories. However, con-
sidering the coverage provided by the Italian National Health System in case of chronic dis-
eases, the proportion of exams performed in private labs should be negligible. Furthermore,
information about comorbidities that could contribute to choosing the most suitable plan was
not completely available. Finally, we do not know what patients’ preferences are for a care
plan.
In conclusion, patients are more often allocated to more a specialized setting than not: two-
thirds of eligible patients are included in the integrated care plan while one-sixth of patients
included in the integrated care plan are not eligible for this less specialised care setting. Health-
care provider-related factors are the most important determinants of over- and underuse of
the integrated care plan.
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